AbbVie's profit rises 19 percent on Humira demand

(Reuters) - U.S. drugmaker AbbVie Inc reported an 18.9 percent rise in quarterly profit on Friday on strong demand for its flagship rheumatoid arthritis drug, Humira.

Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news